Personal information

Emails & domains

Verified email addresses

Other IDs

Scopus Author ID: 57203296320

Activities

Collapse all

Employment (5)

University of Leicester: Leicester, GB

2017-09-01 to present | GSK / Asthma+Lung UK Chair in Respiratory Research (Department of Health Sciences)
Employment
Source: Self-asserted source
Louise Wain

University of Leicester: Leicester, Leicestershire, GB

2015-05-01 to 2017-08-31 | Associate Professor (Department of Health Sciences)
Employment
Source: Self-asserted source
Louise Wain

University of Leicester: Leicester, Leicestershire, GB

2011-09-01 to 2015-04-30 | Lecturer (Department of Health Sciences)
Employment
Source: Self-asserted source
Louise Wain

University of Leicester: Leicester, Leicestershire, GB

2007-08-13 to 2011-08-31 | Postdoctoral Research Associate (Department of Health Sciences)
Employment
Source: Self-asserted source
Louise Wain

University of Nottingham: Nottingham, Nottinghamshire, GB

2005-11-01 to 2007-06-30 | Research Associate (School of Biology)
Employment
Source: Self-asserted source
Louise Wain

Education and qualifications (4)

University of Leicester: Leicester, Leicestershire, GB

2016 to present | Fellow of the Higher Education Academy
Qualification
Source: Self-asserted source
Louise Wain

University of Nottingham: Nottingham, Nottinghamshire, GB

2002 to 2007 | PhD Genetics
Qualification
Source: Self-asserted source
Louise Wain

University of Manchester: Manchester, Greater Manchester, GB

2000 to 2001 | • MSc Bioinformatics - distinction
Qualification
Source: Self-asserted source
Louise Wain

University of Manchester: Manchester, Greater Manchester, GB

1997 to 2000 | • BSc (hons) Life sciences (microbiology and molecular biology) – 2.1
Qualification
Source: Self-asserted source
Louise Wain

Professional activities (4)

Medical Research Council: London, GB

2023-04-01 to present | Deputy Chair of Population and Systems Medicine Board
Invited position
Source: Self-asserted source
Louise Wain

Medical Research Council: London, GB

2022-02-22 to present | Populations and Systems Medicine Board member
Invited position
Source: Self-asserted source
Louise Wain

European Respiratory Society Publications: Sheffield, Sheffield, GB

2018-01-01 to present | Associate Editor (European Respiratory Journal)
Invited position
Source: Self-asserted source
Louise Wain

PROFILE IPF cohort study: London / Nottingham, GB

2017 to present | Genetics lead (Steering Committee)
Invited position
Source: Self-asserted source
Louise Wain

Funding (6)

Genetics Of Rare Polygenic Interstitial Lung Disease

2025-01 to 2027-12 | Grant
Medical Research Council (London, GB)
Source: Self-asserted source
Louise Wain

A double blind, randomised placebo-controlled trial of Tocilizumab in adults with persistent symptoms and raised C-reactive protein at least six months after a hospital admission with COVID-19.

Grant
Roche (United States) (San Francisco, US)
Source: Self-asserted source
Louise Wain

Applying a multidisciplinary approach to defining molecular pathways in lung function impairment (functional genomics for COPD)

Grant
Wellcome Trust (London, GB)
Source: Self-asserted source
Louise Wain

Defining Endotypes of Pulmonary Fibrosis by Understanding the Functional Consequences of Known, and Novel, Genetic Associations with Disease

Grant
Medical Research Council (London, GB)
Source: Self-asserted source
Louise Wain

DEfining MechanIsms Shared across mulTI-organ FIbrosis to prevent the development of long-term multi-morbidity (DEMISTIFI)

Grant
Medical Research Council (London, GB)
Source: Self-asserted source
Louise Wain

Efficient, scalable phenome-wide association studies in drug development

Grant
Orion Corporation (Finland) (Finland, FI)
Source: Self-asserted source
Louise Wain

Peer review (15 reviews for 7 publications/grants)

Review activity for EBioMedicine. (2)
Review activity for Faculty Opinions (5)
Review activity for Nature communications (1)
Review activity for Nature genetics. (1)
Review activity for PLOS genetics. (1)
Review activity for The Journal of infection. (1)
Review activity for Thorax (4)
How many people are using ORCID?